ATP1A2 and neoplasm: Multivariate analysis showed that primary therapy outcome (p < 0.001), residual tumor (p = 0.004), ATP1A2 (p = 0.006), ATP1A3 (p < 0.001), and ATP1A4 (p < 0.001) were independent risk factors for OS (Table 2).